Lipid-based Polyene Antifungal [EPC]

12943 reported adverse events

Drugs of this class: AMPHOTERICIN B AMPHOTERICIN B, DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- AND DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-

These side effects are most commonly reported by patients taking drugs of the Lipid-based Polyene Antifungal [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	2527
1	OFF LABEL USE	1204
2	PYREXIA	793
3	CONDITION AGGRAVATED	512
4	SEPSIS	506
5	FEBRILE NEUTROPENIA	503
6	PNEUMONIA	470
7	HYPOKALAEMIA	465
8	ACUTE KIDNEY INJURY	400
9	RENAL IMPAIRMENT	397

See all common reactions for Lipid-based Polyene Antifungal [EPC]

Drugs of the Lipid-based Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	VASCULAR ANASTOMOTIC HAEMORRHAGE	15	0.6250
1	PANCREATIC CYSTADENOMA	9	0.4500
2	VENA CAVA INJURY	22	0.2750
3	CHOROIDITIS	67	0.2367
4	HEPATOSPLENIC CANDIDIASIS	25	0.2137
5	PERINEAL CYST	11	0.2037
6	DIAPHRAGMATIC INJURY	12	0.1935
7	PYELONEPHRITIS FUNGAL	8	0.1860
8	GEOTRICHUM INFECTION	30	0.1765
9	FUNGAL ENDOCARDITIS	34	0.1700

See all enriched reactions for Lipid-based Polyene Antifungal [EPC]